Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and risk of in situ breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Cohort
In situ breast cancer
Lifestyle
Lifestyle Score
Prevention
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
02 12 2019
02 12 2019
Historique:
received:
18
07
2019
accepted:
08
10
2019
entrez:
3
12
2019
pubmed:
4
12
2019
medline:
24
4
2020
Statut:
epublish
Résumé
Even though in situ breast cancer (BCIS) accounts for a large proportion of the breast cancers diagnosed, few studies have investigated potential risk factors for BCIS. Their results suggest that some established risk factors for invasive breast cancer have a similar impact on BCIS risk, but large population-based studies on lifestyle factors and BCIS risk are lacking. Thus, we investigated the association between lifestyle and BCIS risk within the European Prospective Investigation into Cancer and Nutrition cohort. Lifestyle was operationalized by a score reflecting the adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations. The recommendations utilized in these analyses were the ones pertinent to healthy body weight, physical activity, consumption of plant-based foods, energy-dense foods, red and processed meat, and sugary drinks and alcohol, as well as the recommendation on breastfeeding. Cox proportional hazards regression was used to assess the association between lifestyle score and BCIS risk. The results were presented as hazard ratios (HR) and corresponding 95% confidence intervals (CI). After an overall median follow-up time of 14.9 years, 1277 BCIS cases were diagnosed. Greater adherence to the WCRF/AICR cancer prevention recommendations was not associated with BCIS risk (HR = 0.98, 95% CI 0.93-1.03; per one unit of increase; multivariable model). An inverse association between the lifestyle score and BCIS risk was observed in study centers, where participants were recruited mainly via mammographic screening and attended additional screening throughout follow-up (HR = 0.85, 95% CI 0.73-0.99), but not in the remaining ones (HR = 0.99, 95% CI 0.94-1.05). While we did not observe an overall association between lifestyle and BCIS risk, our results indicate that lifestyle is associated with BCIS risk among women recruited via screening programs and with regular screening participation. This suggests that a true inverse association between lifestyle habits and BCIS risk in the overall cohort may have been masked by a lack of information on screening attendance. The potential inverse association between lifestyle and BCIS risk in our analyses is consistent with the inverse associations between lifestyle scores and breast cancer risk reported from previous studies.
Sections du résumé
BACKGROUND
Even though in situ breast cancer (BCIS) accounts for a large proportion of the breast cancers diagnosed, few studies have investigated potential risk factors for BCIS. Their results suggest that some established risk factors for invasive breast cancer have a similar impact on BCIS risk, but large population-based studies on lifestyle factors and BCIS risk are lacking. Thus, we investigated the association between lifestyle and BCIS risk within the European Prospective Investigation into Cancer and Nutrition cohort.
METHODS
Lifestyle was operationalized by a score reflecting the adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations. The recommendations utilized in these analyses were the ones pertinent to healthy body weight, physical activity, consumption of plant-based foods, energy-dense foods, red and processed meat, and sugary drinks and alcohol, as well as the recommendation on breastfeeding. Cox proportional hazards regression was used to assess the association between lifestyle score and BCIS risk. The results were presented as hazard ratios (HR) and corresponding 95% confidence intervals (CI).
RESULTS
After an overall median follow-up time of 14.9 years, 1277 BCIS cases were diagnosed. Greater adherence to the WCRF/AICR cancer prevention recommendations was not associated with BCIS risk (HR = 0.98, 95% CI 0.93-1.03; per one unit of increase; multivariable model). An inverse association between the lifestyle score and BCIS risk was observed in study centers, where participants were recruited mainly via mammographic screening and attended additional screening throughout follow-up (HR = 0.85, 95% CI 0.73-0.99), but not in the remaining ones (HR = 0.99, 95% CI 0.94-1.05).
CONCLUSIONS
While we did not observe an overall association between lifestyle and BCIS risk, our results indicate that lifestyle is associated with BCIS risk among women recruited via screening programs and with regular screening participation. This suggests that a true inverse association between lifestyle habits and BCIS risk in the overall cohort may have been masked by a lack of information on screening attendance. The potential inverse association between lifestyle and BCIS risk in our analyses is consistent with the inverse associations between lifestyle scores and breast cancer risk reported from previous studies.
Identifiants
pubmed: 31787099
doi: 10.1186/s12916-019-1444-0
pii: 10.1186/s12916-019-1444-0
pmc: PMC6886197
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
221Subventions
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Références
Int J Cancer. 2006 Apr 1;118(7):1782-9
pubmed: 16231317
Int J Cancer. 2017 Jul 1;141(1):83-93
pubmed: 28380695
PLoS One. 2015 Jul 24;10(7):e0132684
pubmed: 26208331
Eur J Epidemiol. 2001;17(11):1047-53
pubmed: 12380720
Arch Intern Med. 2007 Feb 26;167(4):408-15
pubmed: 17325304
Am J Epidemiol. 2017 Dec 15;186(12):1329-1340
pubmed: 28637226
JAMA Oncol. 2018 Nov 1;4(11):e181771
pubmed: 29931120
CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95
pubmed: 26431342
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Am J Public Health. 2010 Nov;100(11):2288-95
pubmed: 20864719
Breast Cancer Res. 2013 Jan 29;15(1):R9
pubmed: 23360535
Int J Cancer. 2012 Aug 15;131(4):930-7
pubmed: 21952983
J Natl Cancer Inst. 2004 Jun 16;96(12):906-20
pubmed: 15199110
Addiction. 2013 Dec;108(12):2051-7
pubmed: 23297738
Int J Cancer. 2014 Nov 15;135(10):2444-52
pubmed: 24723234
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1498-508
pubmed: 23780838
Am J Clin Nutr. 2012 Jul;96(1):150-63
pubmed: 22592101
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
PLoS One. 2015 May 15;10(5):e0126096
pubmed: 25978407
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Int J Cancer. 2017 Feb 15;140(4):764-776
pubmed: 27798951
Int J Epidemiol. 1997;26 Suppl 1:S15-25
pubmed: 9126530
Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2209-19
pubmed: 23074288
Public Health Nutr. 2015 Dec;18(18):3337-48
pubmed: 25805146
Br J Nutr. 2015 Jul 14;114(1):134-43
pubmed: 26051510
Int J Cancer. 2016 Jun 1;138(11):2602-15
pubmed: 26756307
Cancer Causes Control. 2015 Feb;26(2):277-286
pubmed: 25559553
Int J Cancer. 2016 Jun 1;138(11):2657-64
pubmed: 26804371